<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="18465">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02866513</url>
  </required_header>
  <id_info>
    <org_study_id>2015-19</org_study_id>
    <nct_id>NCT02866513</nct_id>
  </id_info>
  <brief_title>Transpulmonary Pressure and Airway Pressure Release Ventilation (APRV).</brief_title>
  <official_title>Incidence of High Levels of Transpulmonary Pressure During the Use of Airway Pressure Release Ventilation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mechanical ventilation can induce pulmonary lesions called ventilator induced lung injury
      (VILI). High levels of Transpulmonary pressure is one of the most important mechanism of
      VILI during the use of mechanical ventilation. The use of bilevel pressure ventilator modes
      like APRV could generate high levels of transpulmonary pressure.

      The aim of this study is to evaluate the variations of transpulmonary pressure during the
      use of APRV by clinicians
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Transpulmonary pressure</measure>
    <time_frame>24 hours</time_frame>
    <description>Measurement of transpulmonary pressure needs the measurement of oesophageal pressure with a specific nasogastric tube. This measurement is now available in routine in few mechanical ventilators in intensive care units (eg: AVEA Ventilator. Vyasys HealthCare). Transpulmonary pressure is the difference between airway pressure and oesophageal pressure and it is now easy to obtain and monitor at the bedside with these ventilators. It is also possible to record the value furthermore than 24 hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximal value of transpulmonary pressure</measure>
    <time_frame>24 hours</time_frame>
    <description>Value of tidal volume &gt; 8 ml/kg</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Patient Mechanically Ventilated With APRV Mode</condition>
  <arm_group>
    <arm_group_label>Patient mechanically ventilated with APRV mode</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>evaluate the variations of transpulmonary pressure during the use of APRV by clinicians.</intervention_name>
    <arm_group_label>Patient mechanically ventilated with APRV mode</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult

          -  Patient mechanically ventilated for more than 48 H for acute respiratory failure

          -  Decision to use of the APRV mode by clinicians in charge of the patient

        Exclusion Criteria:

        - Contraindication for the use of a nasogastric tube
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Urielle DESALBRES</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marc GAINNIER</last_name>
    <phone>(0)4 13 42 85 31</phone>
    <phone_ext>+33</phone_ext>
    <email>marc.gainnier@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assistance Publique Hôpitaux de Marseille hôpital de la Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc GAINNIER</last_name>
      <phone>04 13 42 85 31</phone>
      <email>marc.gainnier@ap-hm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 10, 2016</lastchanged_date>
  <firstreceived_date>August 2, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
